Skip to main content
. Author manuscript; available in PMC: 2015 May 15.
Published in final edited form as: Cancer Res. 2014 Mar 19;74(10):2785–2795. doi: 10.1158/0008-5472.CAN-13-3176

Figure 1. Localization of endogenous CLPTM1L in pancreatic cells and co-localization of CLPTM1L with cytoplasmic organelles.

Figure 1

(A) Localization of endogenous CLPTM1L in PANC-1 pancreatic cancer cells. Cytoplasmic and punctate nuclear, or nuclear membrane, staining is seen (red). Counter staining was performed for α-tubulin (green). (B) Co-localization of WT CLPTM1L (red) with the Endoplasmic Reticulum (ER) marker Calnexin (green) in PANC-1 cells stably transfected with WT CLPTM1L. Co-localization of WT CLPTM1L (red) with a mitochondrial marker (green) (C), or a Golgi marker (GM130 in green) (D), was not seen in PANC-1 cells stably transfected with WT CLPTM1L. Cells in all panels were counterstained with DAPI (blue).